Resume

Responsible for preclinical development and IPR.

Specialist in AKI-051s active ingredient, developed diagnostic technology based on the active ingredient of AKI-051 for the early diagnosis of AKI.

Considerable experience in clinical medicine and biomedical research in both publicly financed research institutions and the pharmaceutical industry.

Professor Dr. Uttenthal is a former researcher at the Universities of Oxford, London and Madrid and was Professor in Biochemistry at the University of Salamanca.

He has over 45 years of experience in clinical medicine and biomedical research, as well as 18 years’ experience in directing R&D in the medical industry.

Many years of experience with the conception and defence of patents applications and ensuring the relevance of claims to clinical endpoints.